Titles and Roles
- Professor, Surgical Oncology Research and Radiology and Imaging Sciences
- Emory University School of Medicine
- Research Program
- Cancer Cell Biology
Lily Yang, MD, PhD is a professor of surgery and radiology and a prominent researcher. Dr. Yang's research experiences include tumor immunology, cancer stem cells, cancer gene therapy, apoptosis resistance, molecular targeted cancer therapy, nanoparticle imaging probes, and theranostic nanoparticles for targeted cancer therapy and imaging.
Dr. Yang is a member of the Cancer Cell Biology Research Program at Winship Cancer Institute. She holds professional memberships with American Association for Cancer Research, American Society of Nanomedicine and National Cancer Institute Alliance for Nanotechnology in Cancer. She is also a Chartered Member in the Study Section of the Development of Therapeutics at NIH.
Dr. Yang received her medical training in China at West China University of Medical Sciences and at the Chinese Academy of Preventive Medicine. She received her PhD in molecular and cellular biology at Brown University. She had postdoctoral trainings in the Gene Therapy Laboratories at University of Southern California and in the Department of Genetics and Molecular Medicine Center at Emory University.
Dr. Yang received an Avon Scholar Award for Breast Cancer Research and is the Nancy Panoz Chair of Surgery in Cancer Research.
Dr. Yang's research projects focus on the development of novel cancer nanotechnologies and imaging methods to address the major challenges in clinical oncology of early cancer detection, targeted drug delivery, overcoming drug resistance, assessment of therapeutic response using non-invasive imaging, and image-guided surgery.
Dr. Yang is a member of the editorial boards of a variety of scientific journals, such as Apoptosis, Nanomedicine: Nanotechnology, Biology and Medicine, Theranostics, Breast Cancer-Targets and Therapy, American Journal of Nuclear Medicine, and Molecular Imaging. She has served as a scientist reviewer for multiple NIH study sections, the Breast Cancer Research Program of the Department of Defense, the National Science Foundation, and the California Breast Cancer Research Program as well as many other national and international funding agents.